Insider Transactions in Q2 2023 at Reata Pharmaceuticals Inc (RETA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,343
-8.6%
|
$238,986
$102.11 P/Share
|
|
Jun 14
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+5.42%
|
$42,174
$27.32 P/Share
|
|
Jun 13
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
78,085
-11.01%
|
$7,964,670
$102.89 P/Share
|
|
Jun 13
2023
|
Manmeet Singh Soni COO, CFO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+15.48%
|
$675,000
$27.32 P/Share
|
|
Jun 12
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
4,711
-4.06%
|
$466,389
$99.62 P/Share
|
|
Jun 12
2023
|
Rajiv Patni EVP, Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+50.0%
|
-
|
|
Jun 07
2023
|
Steven Ryder Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,029
+8.49%
|
$188,697
$93.61 P/Share
|
|
Jun 07
2023
|
Shamim Ruff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+13.0%
|
$198,648
$93.61 P/Share
|
|
Jun 07
2023
|
William D. Mc Clellan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,788
+12.12%
|
$166,284
$93.61 P/Share
|
|
Jun 07
2023
|
Christy J. Oliger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,682
+23.21%
|
$156,426
$93.61 P/Share
|
|
Jun 07
2023
|
Martin Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,815
+12.24%
|
$168,795
$93.61 P/Share
|
|
May 16
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
417
-0.88%
|
$33,360
$80.99 P/Share
|
|
May 16
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
625
-0.54%
|
$50,000
$80.93 P/Share
|
|
May 16
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
625
-0.79%
|
$50,000
$80.94 P/Share
|
|
May 16
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
136
-0.53%
|
$11,016
$81.1 P/Share
|
|
May 16
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
352
-0.88%
|
$28,512
$81.37 P/Share
|
|
May 16
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
417
-1.33%
|
$33,360
$80.95 P/Share
|
|
May 16
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
313
-0.98%
|
$25,353
$81.02 P/Share
|
|
May 15
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
894
-1.86%
|
$75,096
$84.81 P/Share
|
|
May 15
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
21,507
-5.4%
|
$1,806,588
$84.94 P/Share
|
|
May 15
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
5,608
-3.35%
|
$476,680
$85.26 P/Share
|
|
May 15
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
950
-3.55%
|
$80,750
$85.98 P/Share
|
|
May 15
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
288
-0.72%
|
$24,480
$85.32 P/Share
|
|
May 15
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
894
-2.78%
|
$75,990
$85.09 P/Share
|
|
May 15
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
103
-0.32%
|
$8,652
$84.71 P/Share
|
|
May 12
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
6,750
-17.42%
|
$580,500
$86.26 P/Share
|
|
May 05
2023
|
Manmeet Singh Soni COO, CFO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.55%
|
-
|